Have a personal or library account? Click to login
Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients Cover

Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients

European Pharmaceutical Journal
Volume 70 (2023): Issue 1 (December 2023)
By: M. Salari,  M. Sahebary,  M. Sarafraz and  T. Asadi Sakhmarresi  
Open Access
|Sep 2023

Authors

M. Salari

Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

M. Sahebary

sahebarim@mums.ac.ir

Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

M. Sarafraz

Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

T. Asadi Sakhmarresi

Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
DOI: https://doi.org/10.2478/afpuc-2023-0003 | Journal eISSN: 2453-6725
Journal RSS Feed
Language: English
Page range: 21 - 29
Submitted on: Feb 13, 2021
Accepted on: Jun 22, 2023
Published on: Sep 30, 2023
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
autoimmunity,
Raloxifene,
rheumatoid arthritis,
Osteoporosis,
Postmenopausal
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 M. Salari, M. Sahebary, M. Sarafraz, T. Asadi Sakhmarresi, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 70 (2023): Issue 1 (December 2023)